Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Therapy With Bromocriptine in Patients With Symptomatic Risperidone-Induced Hyperprolactinemia

NCT00315081 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT00315081
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00315081 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Therapy With Bromocriptine in Patients With Symptomatic Risperidone-Induced Hyperprolactinemia
Lead sponsor
University Hospital, Bonn
Phase
Phase 3
Overall status
Unknown status
Start date
May 31, 2006
Completion date
May 31, 2008
Enrollment
20
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hyperprolactinemia, schizophrenia